SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-164558
Filing Date
2024-06-20
Accepted
2024-06-20 17:08:00
Documents
8
Effectiveness Date
2024-06-20

Document Format Files

Seq Description Document Type Size
1 S-8 d857872ds8.htm S-8 53106
2 EX-4.4 d857872dex44.htm EX-4.4 6058
3 EX-5.1 d857872dex51.htm EX-5.1 6008
4 EX-23.1 d857872dex231.htm EX-23.1 1537
5 EX-FILING FEES d857872dexfilingfees.htm EX-FILING FEES 20000
6 GRAPHIC g857872dsp17ab.jpg GRAPHIC 13167
7 GRAPHIC g857872dsp17bb.jpg GRAPHIC 77882
8 GRAPHIC g857872g0619065832259.jpg GRAPHIC 1956
  Complete submission text file 0001193125-24-164558.txt   216563
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280360 | Film No.: 241057377
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)